ArticleJournal of patient-reported outcomes2022

Psychometric performance of the Primary Mitochondrial Myopathy Symptom Assessment (PMMSA) in a randomized, double-blind, placebo-controlled crossover study in subjects with mitochondrial disease.

Chad Gwaltney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.